Cannabis use may predict opioid use in women undergoing addictions treatment, study says

March 29, 2017

Hamilton, ON (March 30, 2017) - A new study suggests that the use of cannabis may impact treatment in women undergoing methadone treatment therapy.

Researchers from McMaster University and St. Joseph's Healthcare Hamilton have found that women in methadone treatment who use cannabis are 82 per cent more likely to continue using opioids. This means that women who use cannabis are at high risk of failing methadone treatment.

"About 60 per cent of men and 44 per cent of women who are undergoing methadone treatment therapy also use cannabis," said the study's senior author, Dr. Zena Samaan. "Tailoring treatment to the patient's sex can help us to assess the patient's risk better and deliver more accurate, personalized treatment."

These findings could influence the way in which women diagnosed with opioid use disorder are treated.

Samaan is an associate professor of psychiatry and behavioural neurosciences at McMaster University and a clinician and researcher at St. Joseph's Healthcare Hamilton.

"As cannabis use seems to be a predictor for continuing opioid use despite treatment with methadone, clinicians should screen for cannabis and use these screening results to better plan treatment and resource allocation," said Samaan.

The research team recruited 777 participants from 16 Canadian Addiction Treatment Centre sites across Ontario.

The latest Canadian Tobacco, Alcohol and Drugs Survey taken in 2013 found that two per cent of Canadians reportedly abused opioids. The Canadian Centre on Substance Abuse reports that opioid-related deaths increased by over 240 per cent between 1990 and 2010.

The study was published online in Biology of Sex Differences and was funded by the Canadian Institutes of Health Research, the Chanchlani Research Centre and the Peter Boris Centre for Addictions Research.

To book an interview, please contact:

Maria Hayes
Senior Public Affairs Specialist
Public Affairs Department
St. Joseph's Healthcare Hamilton
T: 905-522-1155 ext. 33506
mhayes@stjoes.ca

Veronica McGuire,
Media Relations Co-ordinator
Faculty of Health Sciences
McMaster University
T: (905) 525-9140, ext. 22169
vmcguir@mcmaster.ca

Veronica McGuire
Media Relations, Faculty of Health Sciences,
McMaster University
(905) 525-9140, ext. 22169
vmcguir@mcmaster.ca
-end-


McMaster University

Related Cannabis Articles from Brightsurf:

Cannabis to treat gynecological conditions
A significant number of women would consider using cannabis to treat gynecological conditions, primarily gynecological pain.

Cannabis data lacking, but machine learning could help
Everyone's heard of THC and CBD. But many other active compounds in cannabis interact to influence its effects.

Cannabis use for menopause symptom management
CLEVELAND, Ohio (September 28, 2020)--As legislation relaxes regarding cannabis, it is being used to manage numerous chronic health conditions and mood symptoms.

Prescribed CBD could help people quit cannabis
A benchmark clinical trial published today shows that cannabidiol (CBD) could be a safe and effective treatment for problematic cannabis use.

Pregnant women with depression are more than 3 times more likely to use cannabis
Cannabis use is much more common among pregnant women with depression and pregnant women with depression are more than 3 times more likely to use cannabis than those without depression.

Cannabis compound acts as an antibiotic 
Public health agencies worldwide have identified antibiotic resistance of disease-causing bacteria as one of humanity's most critical challenges.

Cannabis use during pregnancy
The large health care system Kaiser Permanente Northern California provides universal screening for prenatal cannabis use in women during pregnancy by self-report and urine toxicology testing.

Questions and answers about cannabis use during pregnancy
A new study shows that women have many medical questions about the use of cannabis both before and during pregnancy, and during the postpartum period while breastfeeding.

Managing cannabis use in breastfeeding women
As more states legalize medicinal and recreational cannabis use and increasingly decriminalize cannabis, the risk to the growth and development of breastfeeding infants whose mothers use cannabis becomes a growing public health concern.

Cannabis edibles present novel health risks
With the recent legalization of cannabis edibles in Canada, physicians and the public must be aware of the novel risks of cannabis edibles, argue authors in a commentary in CMAJ (Canadian Medical Association Journal).

Read More: Cannabis News and Cannabis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.